Intervention not reported
Venous thromboembolic events (number of participants with at least one venous thromboembolic events) Time: 5‐week · adult women with advanced EOC undergoing cytoreductive surgery (one randomised trial available)
It is very uncertain whether the intervention changes venous thromboembolic events (number of participants with at least… (very low certainty).
1 finding from 1 review
- Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer 2016 · Cochrane Headline outcomes onlyRR 0.5 [0.1, 2.61]1 study · 100 participantsVery low